Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04269902
Brief Title: Testing the Effects of Early Treatment With Venetoclax and Obinutuzumab Versus Delayed Treatment With Venetoclax and Obinutuzumab for Newly Diagnosed Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Do Not Have Symptoms, the EVOLVE CLL/SLL Study

First Submitted : February 13, 2020
First Submitted that Met QC Criteria : February 13, 2020
First Posted : February 17, 2020

Last Update Submitted that Met QC Criteria : July 27, 2021
Last Update Posted : July 28, 2021 (Estimate)